샘플 요청 목록

 카트 문의
시장보고서
상품코드
1616450

헬스케어 업계 진단 분석 시장 - 규모, 점유율, 동향 분석 : 전개 모드별, 데이터 소스별, 최종 사용자별, 유형별, 기술별, 용도별, 지역별, 전망과 예측(2024-2031년)

Global Diagnostic Analytics in Healthcare Industry Market Size, Share & Trends Analysis Report By Deployment Mode, By Data Source, By End-User, By Type, By Technology, By Application, By Regional Outlook and Forecast, 2024 - 2031
발행일: | 리서치사: KBV Research | 페이지 정보: 영문 515 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 헬스케어 업계 진단 분석 시장 규모는 예측 기간 동안 29.0%의 연평균 복합 성장률(CAGR)로 성장하여 2031년까지 618억 달러에 달할 것으로 예상되고 있습니다.

KBV Cardinal matrix: 헬스케어 업계 시장 경쟁 분석의 진단 분석

KBV Cardinal matrix에 제시된 분석에 따라 F. Hoffmann-La Roche Ltd.는 헬스케어 산업 시장 진단 분석의 선구자입니다. Hoffmann-La Roche Ltd.는 PathAI와 제휴하여 동반진단용 AI 탑재 디지털 병리학 알고리즘을 개발했습니다. 정밀의료가 진보되고 표적 치료가 강화되고 있습니다.

COVID-19의 영향 분석

COVID-19 팬데믹은 헬스케어 업계에서 진단 분석의 도입과 성장에 큰 혼란을 가져왔습니다. 장기 프로젝트에서 유행에 대한 즉각적인 대응으로 자원 주력을 향해 왔습니다. 여러 가지 비 호환성 소스에서 COVID-19 관련 데이터가 급증함에 따라 큰 통합 문제가 발생하고 분석을 수행하고 실행 가능한 통찰력을 도출하는 노력이 더욱 복잡해졌습니다. 따라서 유행은 시장 전체에 악영향을 미쳤습니다.

시장 성장 요인

개인화된 의료 수요가 증가함에 따라 환자별 데이터를 기반으로 맞춤형 치료 계획이 가능해져 건강 관리가 변화합니다. 같은 도구를 활용하여 유전자, 임상, 행동 데이터를 분석하여 정확한 의료 솔루션을 제공합니다. Foundation Medicine의 유전체 프로파일링 도구는 종양 전문의가 종양 특유의 유전자 변이를 확인하고 치료 결과를 크게 향상시키는 표적 치료를 수행하는 데 도움이 됩니다.

또한 의료용 이미지 처리에서는 Google Health 및 Zebra Medical Vision 등의 기업이 개발한 AI 탑재 툴이 X선, MRI, CT 스캔을 매우 높은 정확도로 분석합니다. 인간의 방사선 선과 의사를 능가하는 것은 적지 않습니다. 특히 검사 과정을 가속화하면 심각한 경우에는 보다 신속한 진단과 개입이 가능할 것입니다.

시장 성장 억제요인

그러나 건강 관리 업계에서 진단 분석 솔루션을 도입하려면 많은 비용이 드는 선행 투자가 필요합니다. 이를 통해 건강 관리 직원이 이러한 도구를 효과적으로 사용하는 데 필요한 교육을 수행하는 등 다양한 요소가 포함됩니다.

배포 모드별 전망

배포 모드를 기반으로 시장은 클라우드 기반, 온프레미스, 하이브리드로 분류됩니다. 환자 데이터를 직접 제어하고 HIPAA와 같은 엄격한 건강 관리 규제를 준수하기 위해 온프레미스 솔루션을 선호합니다. 또한 온프레미스 시스템은 조직의 인프라와 워크플로의 특정 요구 사항을 충족하도록 조정되며 종종 클라우드 기반 모델에서는 완벽하게 대응할 수 없는 신뢰성과 거버넌스를 제공합니다.

데이터 소스별 전망

데이터 소스를 기반으로 시장은 임상 데이터, 의료 이미지 데이터, 웨어러블 및 IoT 데이터, 실험실 테스트 데이터, 유전체 데이터로 나뉘어져 있습니다. 이미지 기술의 향상과 머신러닝(ML)과 인공지능(AI)의 조합으로이 부문이 크게 확장되었습니다. 이 혁신은 진단 정확도를 향상시키고 복잡한 이미지 데이터 세트를 분석하여 개별 화된 치료 계획이 가능합니다.

최종 사용자별 전망

최종 사용자별로 시장은 병원, 진단 실험실, 클리닉 및 의사 진료소, 연구 및 학술기관, 보험회사 등으로 분류되어 있습니다. 대량의 테스트 데이터를 관리하고, 처리 시간을 단축하고, 보고서의 정확성을 확보하고 있습니다. 검사실 기반 진단에 대한 의존도가 증가함에 따라 더욱 향상되었습니다.

유형별 전망

유형에 따라 시장은 예측 분석, 처방 분석, 설명 분석 및 진단 분석으로 분류됩니다. 처방 분석 부문은 2023년 시장에서 28%의 수익 공유를 기록했습니다. 치료 계획, 리소스 활용, 스케줄 조정 제안 등 결과를 개선하기 위한 구체적인 액션을 권장합니다.

기술별 전망

기술을 기반으로 시장은 인공지능(AI)과 머신러닝(ML), 빅데이터 분석, 클라우드 기반 분석, 자연언어처리(NLP) 등으로 나뉘어져 있습니다. 분석 솔루션은 헬스케어 업계에서 매일 생성되는 엄청난 양의 데이터를 처리하고 평가하는 데 필요합니다. 환자의 결과를 향상시킬 수 있습니다.

용도별 전망

용도별로 보면, 시장은 질병 검출과 진단, 임상 의사 결정 지원, 맞춤형 치료, 방사선과와 의료용 화상 진단, 환자 모니터링과 원격 진단, 기타로 분류되어 있습니다. 개선 및 의료 실수를 줄이기 위해 데이터 중심의 건강 관리 실천의 채택이 증가함에 따라 추진되고 있습니다. 이 시스템은 실시간 환자 데이터, 증거 기반 지침 및 예측 분석을 활용하여, 임상의가 정보를 기반으로 의사 결정을 내릴 수 있도록 도와줍니다.

지역 전망

지역별로 볼 때 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 아프리카에 걸쳐 분석되고 있습니다. 이 지역의 강력한 규제 프레임워크는 진단 분석 솔루션의 채용을 촉진하고 있습니다.

시장 경쟁과 특성

헬스케어 업계의 진단 분석 시장에서의 경쟁은 주요 기업을 제외하고 혁신적인 솔루션을 제공하는 신흥 기업과 틈새 기업의 존재를 특징으로 하고 있습니다. 첨단 분석, 인공지능 구동 툴 및 전문 서비스에 중점을 둡니다.

목차

제1장 시장 범위와 조사 방법

  • 시장의 정의
  • 목적
  • 시장 범위
  • 세분화
  • 조사 방법

제2장 시장 요람

  • 주요 하이라이트

제3장 시장 개요

  • 소개
    • 개요
      • 시장구성과 시나리오
  • 시장에 영향을 미치는 주요 요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
    • 시장의 과제

제4장 경쟁 분석- 세계

  • KBV Cardinal Matrix
  • 최근 업계 전체의 전략적 전개
    • 파트너십, 협업 및 계약
    • 제품 출시 및 제품 확대
    • 인수와 합병
  • 시장 점유율 분석 2023년
  • 주요 성공 전략
    • 주요 전략
    • 주요 전략적 움직임
  • Porter's Five Forces 분석

제5장 세계 시장 : 전개 모드별

  • 세계 클라우드 기반 시장 : 지역별
  • 세계의 온프레미스 시장 :지역별
  • 세계의 하이브리드 시장 :지역별

제6장 세계 시장 : 데이터 소스별

  • 세계의 임상 데이터 시장 :지역별
  • 세계의 의료 화상 데이터 시장 :지역별
  • 세계의 웨어러블 및 IoT 데이터 시장 :지역별
  • 세계의 실험실 테스트 데이터 시장 : 지역별
  • 세계의 유전체 데이터 시장 :지역별

제7장 세계 시장 : 최종 사용자별

  • 세계의 병원 시장 :지역별
  • 세계의 진단 실험실 시장 :지역별
  • 세계의 클리닉 및 의사 진료소 시장 :지역별
  • 세계의 연구·학술 기관 시장 :지역별
  • 세계 보험 회사 및 기타 시장 : 지역별

제8장 세계 시장 : 유형별

  • 세계 예측 분석 시장 :지역별
  • 세계의 처방 분석 시장 :지역별
  • 세계의 기술 분석 시장 : 지역별
  • 세계의 진단 분석 시장 :지역별

제9장 세계 시장 : 기술별

  • 세계의 인공지능(AI)과 머신러닝(ML) 시장 :지역별
  • 세계의 빅데이터 분석 시장 :지역별
  • 세계 클라우드 기반 분석 시장 : 지역별
  • 세계의 자연언어처리(NLP) 시장 :지역별
  • 세계의 기타 기술 시장 : 지역별

제10장 세계 시장 : 용도별

  • 세계의 질병 검출·진단 시장 :지역별
  • 세계의 임상 의사 결정 지원 시장 :지역별
  • 세계의 맞춤형 치료 시장 :지역별
  • 세계의 방사선·의료 화상 시장 :지역별
  • 세계의 환자 모니터링 및 원격 진단 시장 :지역별
  • 세계의 다른 용도 시장 :지역별

제11장 세계 시장 : 지역별

  • 북미
    • 북미 시장 : 국가별
      • 미국
      • 캐나다
      • 멕시코
      • 기타 북미
  • 유럽
    • 유럽 시장 : 국가별
      • 독일
      • 영국
      • 프랑스
      • 러시아
      • 스페인
      • 이탈리아
      • 기타 유럽
  • 아시아태평양
    • 아시아태평양 시장 : 국가별
      • 중국
      • 일본
      • 인도
      • 한국
      • 싱가포르
      • 말레이시아
      • 기타 아시아태평양
  • 라틴아메리카· 중동· 아프리카
    • 라틴아메리카· 중동· 아프리카 시장 : 국가별
      • 브라질
      • 아르헨티나
      • 아랍에미리트(UAE)
      • 사우디아라비아
      • 남아프리카
      • 나이지리아
      • 기타 라틴아메리카· 중동· 아프리카

제12장 기업 프로파일

  • Siemens Healthineers AG(Siemens AG)
  • Abbott Laboratories
  • F Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Qiagen NV
  • Medtronic PLC
  • Illumina, Inc
  • Thermo Fisher Scientific, Inc
  • Quest Diagnostics Incorporated
  • GE HealthCare Technologies, Inc

제13장 헬스케어 업계 시장에서의 진단 분석의 필수 요건

JHS 25.01.09

The Global Diagnostic Analytics In Healthcare Industry Market size is expected to reach $61.8 billion by 2031, rising at a market growth of 29.0% CAGR during the forecast period.

The North America segment garnered 39% revenue share in the market in 2023. This supremacy is explained by the region's substantial investments in healthcare analytics, strong adoption of cutting-edge technologies, and well-established healthcare infrastructure. Growth has been further accelerated by the existence of significant market participants and robust government measures to support healthcare IT.

The major strategies followed by the market participants are Partnership as the key developmental strategy to keep pace with the changing demands of end users. For instance, In March, 2023, Siemens Healthineers AG entered into a 7-year strategic partnership with Aster DM Healthcare, aiming to advance healthcare innovation across the UAE and GCC. The collaboration focuses on technology upgrades, digital optimization, workflow improvements, and continuous education to enhance operational efficiency and patient care delivery. Moreover, In August, 2024, QIAGEN expanded its partnership with AstraZeneca to develop companion diagnostics for chronic diseases using the QIAstat-Dx platform. This syndromic testing system enables rapid genotyping, supporting precision medicine by tailoring treatments to patients' genetic profiles during routine clinical exams.

KBV Cardinal Matrix - Diagnostic Analytics In Healthcare Industry Market Competition Analysis

Based on the Analysis presented in the KBV Cardinal matrix; F. Hoffmann-La Roche Ltd. is the forerunners in the Diagnostic Analytics in Healthcare Industry Market. In February, 2024, F. Hoffmann-La Roche Ltd. partnered with PathAI to develop AI-powered digital pathology algorithms for companion diagnostics. The collaboration will integrate these algorithms into Roche's navify Digital Pathology platform, advancing precision medicine and enhancing targeted treatments through seamless laboratory integration. Companies such as Illumina Inc., Siemens Healthineers AG and GE HealthCare Technologies, Inc. are some of the key innovators in Diagnostic Analytics in Healthcare Industry Market.

COVID 19 Impact Analysis

The COVID-19 pandemic significantly disrupted the adoption and growth of diagnostic analytics in the healthcare industry. One of the primary challenges was the overwhelming burden placed on healthcare systems, which redirected resources and attention away from long-term projects like analytics implementation toward immediate pandemic response. The sudden influx of COVID-19-related data from multiple, often incompatible sources created significant integration challenges, further complicating efforts to analyze and derive actionable insights. Thus, the pandemic had an overall negative impact on the market.

Market Growth Factors

The rising demand for personalized medicine transforms healthcare by enabling tailored treatment plans based on patient-specific data. Diagnostic analytics is vital in this transformation, leveraging tools like Foundation Medicine and Caris Life Sciences to analyze genetic, clinical, and behavioral data for precise medical solutions. For instance, Foundation Medicine's genomic profiling tools help oncologists identify tumor-specific genetic mutations, enabling targeted therapies that significantly improve treatment outcomes. Hence, these examples illustrate the transformative impact of diagnostic analytics in personalized medicine.

Additionally, In medical imaging, AI-powered tools developed by companies like Google Health and Zebra Medical Vision analyze X-rays, MRIs, and CT scans with exceptional precision. These tools can detect conditions such as lung and breast cancer as well as brain abnormalities, often surpassing human radiologists in accuracy. Accelerating the review process enables quicker diagnoses and interventions, particularly in critical cases. Thus, the development of these technologies will also drive the expansion of the market.

Market Restraining Factors

However, The adoption of diagnostic analytics solutions in the healthcare industry often comes with a substantial upfront investment. This cost encompasses various components such as purchasing or licensing advanced software, upgrading or acquiring compatible hardware, and ensuring the necessary training for healthcare professionals to use these tools effectively. Many organizations may find these cost constraints burdensome, particularly small-to-medium-sized healthcare facilities.

Deployment Mode Outlook

Based on deployment mode, the market is classified into cloud-based, on-premise, and hybrid. The on-premise segment procured 30% revenue share in the market in 2023. Many healthcare providers prefer on-premise solutions to maintain direct control over sensitive patient data and ensure adherence to stringent healthcare regulations like HIPAA. Furthermore, on-premise systems are often tailored to meet the specific requirements of an organization's infrastructure and workflows, providing a sense of reliability and governance that cloud-based models may not fully address.

Data Source Outlook

On the basis of data source, the market is divided into clinical data, medical imaging data, wearables & IoT data, lab test data, and genomic data. The medical imaging data segment recorded 24% revenue share in the market in 2023. Improvements in imaging technology and the combination of machine learning and artificial intelligence (AI) have led to a notable expansion of the segment. These innovations have enhanced diagnostic accuracy and enabled personalized treatment plans by analyzing complex imaging datasets.

End-User Outlook

By end-user, the market is segmented into hospitals, diagnostic laboratories, clinics & physician practices, research & academic institutes, insurance companies, and others. The diagnostic laboratories segment procured 19% revenue share in the market in 2023. These laboratories leverage analytics tools to manage high volumes of test data, reduce turnaround times, and ensure accuracy in reporting. The adoption of analytics solutions has been further supported by the rising incidence of infectious and chronic diseases as well as a growing dependence on laboratory-based diagnostics.

Type Outlook

Based on type, the market is classified into predictive analytics, prescriptive analytics, descriptive analytics, and diagnostic analytics. The prescriptive analytics segment witnessed 28% revenue share in the market in 2023. This type of analytics recommends specific actions to improve outcomes, such as suggesting optimal treatment plans, resource utilization, or scheduling adjustments. The demand for precision medicine and the increasing complexity of healthcare delivery have made prescriptive analytics more crucial than ever.

Technology Outlook

On the basis of technology, the market is divided into artificial intelligence (AI) & machine learning (ML), Big Data analytics, cloud-based analytics, natural language processing (NLP), and others. The Big Data analytics segment procured 24% revenue share in the market in 2023. Big data analytics solutions are necessary for processing and evaluating the enormous amount of data generated by the healthcare industry every day. By utilizing big data analytics, healthcare organizations can identify trends, optimize resource allocation, and enhance patient outcomes.

Application Outlook

By application, the market is segmented into disease detection & diagnosis, clinical decision support, personalized treatment, radiology & medical imaging, patient monitoring & remote diagnostics, and others. The clinical decision support segment recorded 19% revenue share in the market in 2023. This segment is propelled by the growing adoption of data-driven healthcare practices to improve care quality and reduce medical errors. These systems leverage real-time patient data, evidence-based guidelines, and predictive analytics to assist clinicians in making informed decisions.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment procured 30% revenue share in the market in 2023. The region's robust regulatory framework, aimed at improving data security and patient care, has encouraged the adoption of diagnostic analytics solutions. Additionally, increasing investments in healthcare research and the growing use of artificial intelligence and big data analytics have strengthened the European market.

Market Competition and Attributes

The competition in the Diagnostic Analytics in Healthcare industry market, excluding top players, is marked by the presence of emerging firms and niche players offering innovative solutions. These companies focus on advanced analytics, AI-driven tools, and specialized services to cater to unmet needs. Intense rivalry exists as they strive to differentiate themselves through innovation, cost-efficiency, and tailored customer experiences.

Recent Strategies Deployed in the Market

  • Jun-2024: Illumina has acquired Fluent BioSciences, expanding its multiomics capabilities with innovative single-cell analysis technology. This acquisition aims to make single-cell research more accessible and scalable, enhancing Illumina's portfolio with cost-effective solutions to accelerate discovery and improve diagnostic analytics.
  • May-2024: Danaher Corporation has partnered with Johns Hopkins University to develop improved diagnostic methods for mild traumatic brain injury (TBI) using blood-based biomarkers. The collaboration aims for earlier and more accurate detection, with potential applications for other neurological conditions.
  • Dec-2023: Danaher Corporation has completed its acquisition of Abcam, making the company an indirect wholly owned subsidiary. Following the completion of the deal, Abcam's trading on Nasdaq has been suspended. This marks a significant shift in Danaher's portfolio in life sciences and diagnostics.
  • Oct-2023: Qiagen N.V. and Myriad Genetics have partnered to develop advanced cancer companion diagnostics, leveraging PCR, digital PCR, and NGS technologies. The collaboration aims to enhance global diagnostic solutions, including MRD and HRD assays, improving precision oncology and personalized treatment decisions.
  • Aug-2023: Thermo Fisher Scientific has acquired CorEvitas, enhancing its real-world evidence capabilities with regulatory-grade registries. This supports clinical research and post-approval drug monitoring, advancing biopharma productivity and patient care in key therapeutic areas. The acquisition boosts adjusted earnings in 2024.

List of Key Companies Profiled

  • Siemens Healthineers AG (Siemens AG)
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Qiagen N.V
  • Medtronic PLC
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
  • GE HealthCare Technologies, Inc.

Global Diagnostic Analytics In Healthcare Industry Market Report Segmentation

By Deployment Mode

  • Cloud-Based
  • On-Premise
  • Hybrid

By Data Source

  • Clinical Data
  • Medical Imaging Data
  • Wearables & IoT Data
  • Lab Test Data
  • Genomic Data

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Clinics and Physician Practices
  • Research & Academic Institutes
  • Insurance Companies & Other

By Type

  • Predictive Analytics
  • Prescriptive Analytics
  • Descriptive Analytics
  • Diagnostic Analytics

By Technology

  • Artificial Intelligence (AI) & Machine Learning (ML)
  • Big Data Analytics
  • Cloud-Based Analytics
  • Natural Language Processing (NLP)s
  • Other Technology

By Application

  • Disease Detection & Diagnosis
  • Clinical Decision Support
  • Personalized Treatment
  • Radiology & Medical Imaging
  • Patient Monitoring and Remote Diagnostics
  • Other Application

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Diagnostic Analytics in Healthcare Industry Market, by Deployment Mode
    • 1.4.2 Global Diagnostic Analytics in Healthcare Industry Market, by Data Source
    • 1.4.3 Global Diagnostic Analytics in Healthcare Industry Market, by End-User
    • 1.4.4 Global Diagnostic Analytics in Healthcare Industry Market, by Type
    • 1.4.5 Global Diagnostic Analytics in Healthcare Industry Market, by Technology
    • 1.4.6 Global Diagnostic Analytics in Healthcare Industry Market, by Application
    • 1.4.7 Global Diagnostic Analytics in Healthcare Industry Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
  • 4.3 Market Share Analysis, 2023
  • 4.4 Top Winning Strategies
    • 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
    • 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Dec - 2024, Jun) Leading Players
  • 4.5 Porter Five Forces Analysis

Chapter 5. Global Diagnostic Analytics in Healthcare Industry Market by Deployment Mode

  • 5.1 Global Cloud-Based Market by Region
  • 5.2 Global On-Premise Market by Region
  • 5.3 Global Hybrid Market by Region

Chapter 6. Global Diagnostic Analytics in Healthcare Industry Market by Data Source

  • 6.1 Global Clinical Data Market by Region
  • 6.2 Global Medical Imaging Data Market by Region
  • 6.3 Global Wearables & IoT Data Market by Region
  • 6.4 Global Lab Test Data Market by Region
  • 6.5 Global Genomic Data Market by Region

Chapter 7. Global Diagnostic Analytics in Healthcare Industry Market by End-User

  • 7.1 Global Hospitals Market by Region
  • 7.2 Global Diagnostic Laboratories Market by Region
  • 7.3 Global Clinics and Physician Practices Market by Region
  • 7.4 Global Research & Academic Institutes Market by Region
  • 7.5 Global Insurance Companies & Other Market by Region

Chapter 8. Global Diagnostic Analytics in Healthcare Industry Market by Type

  • 8.1 Global Predictive Analytics Market by Region
  • 8.2 Global Prescriptive Analytics Market by Region
  • 8.3 Global Descriptive Analytics Market by Region
  • 8.4 Global Diagnostic Analytics Market by Region

Chapter 9. Global Diagnostic Analytics in Healthcare Industry Market by Technology

  • 9.1 Global Artificial Intelligence (AI) & Machine Learning (ML) Market by Region
  • 9.2 Global Big Data Analytics Market by Region
  • 9.3 Global Cloud-Based Analytics Market by Region
  • 9.4 Global Natural Language Processing (NLP)s Market by Region
  • 9.5 Global Other Technology Market by Region

Chapter 10. Global Diagnostic Analytics in Healthcare Industry Market by Application

  • 10.1 Global Disease Detection & Diagnosis Market by Region
  • 10.2 Global Clinical Decision Support Market by Region
  • 10.3 Global Personalized Treatment Market by Region
  • 10.4 Global Radiology & Medical Imaging Market by Region
  • 10.5 Global Patient Monitoring and Remote Diagnostics Market by Region
  • 10.6 Global Other Application Market by Region

Chapter 11. Global Diagnostic Analytics in Healthcare Industry Market by Region

  • 11.1 North America Diagnostic Analytics in Healthcare Industry Market
    • 11.1.1 North America Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
      • 11.1.1.1 North America Cloud-Based Market by Country
      • 11.1.1.2 North America On-Premise Market by Country
      • 11.1.1.3 North America Hybrid Market by Country
    • 11.1.2 North America Diagnostic Analytics in Healthcare Industry Market by Data Source
      • 11.1.2.1 North America Clinical Data Market by Region
      • 11.1.2.2 North America Medical Imaging Data Market by Region
      • 11.1.2.3 North America Wearables & IoT Data Market by Region
      • 11.1.2.4 North America Lab Test Data Market by Region
      • 11.1.2.5 North America Genomic Data Market by Region
    • 11.1.3 North America Diagnostic Analytics in Healthcare Industry Market by End-User
      • 11.1.3.1 North America Hospitals Market by Country
      • 11.1.3.2 North America Diagnostic Laboratories Market by Country
      • 11.1.3.3 North America Clinics and Physician Practices Market by Country
      • 11.1.3.4 North America Research & Academic Institutes Market by Country
      • 11.1.3.5 North America Insurance Companies & Other Market by Country
    • 11.1.4 North America Diagnostic Analytics in Healthcare Industry Market by Type
      • 11.1.4.1 North America Predictive Analytics Market by Country
      • 11.1.4.2 North America Prescriptive Analytics Market by Country
      • 11.1.4.3 North America Descriptive Analytics Market by Country
      • 11.1.4.4 North America Diagnostic Analytics Market by Country
    • 11.1.5 North America Diagnostic Analytics in Healthcare Industry Market by Technology
      • 11.1.5.1 North America Artificial Intelligence (AI) & Machine Learning (ML) Market by Country
      • 11.1.5.2 North America Big Data Analytics Market by Country
      • 11.1.5.3 North America Cloud-Based Analytics Market by Country
      • 11.1.5.4 North America Natural Language Processing (NLP)s Market by Country
      • 11.1.5.5 North America Other Technology Market by Country
    • 11.1.6 North America Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.1.6.1 North America Disease Detection & Diagnosis Market by Country
      • 11.1.6.2 North America Clinical Decision Support Market by Country
      • 11.1.6.3 North America Personalized Treatment Market by Country
      • 11.1.6.4 North America Radiology & Medical Imaging Market by Country
      • 11.1.6.5 North America Patient Monitoring and Remote Diagnostics Market by Country
      • 11.1.6.6 North America Other Application Market by Country
    • 11.1.7 North America Diagnostic Analytics in Healthcare Industry Market by Country
      • 11.1.7.1 US Diagnostic Analytics in Healthcare Industry Market
        • 11.1.7.1.1 US Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.1.7.1.2 US Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.1.7.1.3 US Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.1.7.1.4 US Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.1.7.1.5 US Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.1.7.1.6 US Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.1.7.2 Canada Diagnostic Analytics in Healthcare Industry Market
        • 11.1.7.2.1 Canada Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.1.7.2.2 Canada Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.1.7.2.3 Canada Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.1.7.2.4 Canada Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.1.7.2.5 Canada Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.1.7.2.6 Canada Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.1.7.3 Mexico Diagnostic Analytics in Healthcare Industry Market
        • 11.1.7.3.1 Mexico Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.1.7.3.2 Mexico Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.1.7.3.3 Mexico Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.1.7.3.4 Mexico Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.1.7.3.5 Mexico Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.1.7.3.6 Mexico Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.1.7.4 Rest of North America Diagnostic Analytics in Healthcare Industry Market
        • 11.1.7.4.1 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.1.7.4.2 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.1.7.4.3 Rest of North America Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.1.7.4.4 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.1.7.4.5 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.1.7.4.6 Rest of North America Diagnostic Analytics in Healthcare Industry Market by Application
  • 11.2 Europe Diagnostic Analytics in Healthcare Industry Market
    • 11.2.1 Europe Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
      • 11.2.1.1 Europe Cloud-Based Market by Country
      • 11.2.1.2 Europe On-Premise Market by Country
      • 11.2.1.3 Europe Hybrid Market by Country
    • 11.2.2 Europe Diagnostic Analytics in Healthcare Industry Market by Data Source
      • 11.2.2.1 Europe Clinical Data Market by Country
      • 11.2.2.2 Europe Medical Imaging Data Market by Country
      • 11.2.2.3 Europe Wearables & IoT Data Market by Country
      • 11.2.2.4 Europe Lab Test Data Market by Country
      • 11.2.2.5 Europe Genomic Data Market by Country
    • 11.2.3 Europe Diagnostic Analytics in Healthcare Industry Market by End-User
      • 11.2.3.1 Europe Hospitals Market by Country
      • 11.2.3.2 Europe Diagnostic Laboratories Market by Country
      • 11.2.3.3 Europe Clinics and Physician Practices Market by Country
      • 11.2.3.4 Europe Research & Academic Institutes Market by Country
      • 11.2.3.5 Europe Insurance Companies & Other Market by Country
    • 11.2.4 Europe Diagnostic Analytics in Healthcare Industry Market by Type
      • 11.2.4.1 Europe Predictive Analytics Market by Country
      • 11.2.4.2 Europe Prescriptive Analytics Market by Country
      • 11.2.4.3 Europe Descriptive Analytics Market by Country
      • 11.2.4.4 Europe Diagnostic Analytics Market by Country
    • 11.2.5 Europe Diagnostic Analytics in Healthcare Industry Market by Technology
      • 11.2.5.1 Europe Artificial Intelligence (AI) & Machine Learning (ML) Market by Country
      • 11.2.5.2 Europe Big Data Analytics Market by Country
      • 11.2.5.3 Europe Cloud-Based Analytics Market by Country
      • 11.2.5.4 Europe Natural Language Processing (NLP)s Market by Country
      • 11.2.5.5 Europe Other Technology Market by Country
    • 11.2.6 Europe Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.2.6.1 Europe Disease Detection & Diagnosis Market by Country
      • 11.2.6.2 Europe Clinical Decision Support Market by Country
      • 11.2.6.3 Europe Personalized Treatment Market by Country
      • 11.2.6.4 Europe Radiology & Medical Imaging Market by Country
      • 11.2.6.5 Europe Patient Monitoring and Remote Diagnostics Market by Country
      • 11.2.6.6 Europe Other Application Market by Country
    • 11.2.7 Europe Diagnostic Analytics in Healthcare Industry Market by Country
      • 11.2.7.1 Germany Diagnostic Analytics in Healthcare Industry Market
        • 11.2.7.1.1 Germany Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.2.7.1.2 Germany Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.2.7.1.3 Germany Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.2.7.1.4 Germany Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.2.7.1.5 Germany Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.2.7.1.6 Germany Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.2.7.2 UK Diagnostic Analytics in Healthcare Industry Market
        • 11.2.7.2.1 UK Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.2.7.2.2 UK Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.2.7.2.3 UK Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.2.7.2.4 UK Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.2.7.2.5 UK Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.2.7.2.6 UK Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.2.7.3 France Diagnostic Analytics in Healthcare Industry Market
        • 11.2.7.3.1 France Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.2.7.3.2 France Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.2.7.3.3 France Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.2.7.3.4 France Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.2.7.3.5 France Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.2.7.3.6 France Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.2.7.4 Russia Diagnostic Analytics in Healthcare Industry Market
        • 11.2.7.4.1 Russia Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.2.7.4.2 Russia Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.2.7.4.3 Russia Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.2.7.4.4 Russia Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.2.7.4.5 Russia Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.2.7.4.6 Russia Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.2.7.5 Spain Diagnostic Analytics in Healthcare Industry Market
        • 11.2.7.5.1 Spain Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.2.7.5.2 Spain Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.2.7.5.3 Spain Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.2.7.5.4 Spain Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.2.7.5.5 Spain Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.2.7.5.6 Spain Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.2.7.6 Italy Diagnostic Analytics in Healthcare Industry Market
        • 11.2.7.6.1 Italy Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.2.7.6.2 Italy Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.2.7.6.3 Italy Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.2.7.6.4 Italy Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.2.7.6.5 Italy Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.2.7.6.6 Italy Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.2.7.7 Rest of Europe Diagnostic Analytics in Healthcare Industry Market
        • 11.2.7.7.1 Rest of Europe Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.2.7.7.2 Rest of Europe Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.2.7.7.3 Rest of Europe Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.2.7.7.4 Rest of Europe Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.2.7.7.5 Rest of Europe Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.2.7.7.6 Rest of Europe Diagnostic Analytics in Healthcare Industry Market by Application
  • 11.3 Asia Pacific Diagnostic Analytics in Healthcare Industry Market
    • 11.3.1 Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
      • 11.3.1.1 Asia Pacific Cloud-Based Market by Country
      • 11.3.1.2 Asia Pacific On-Premise Market by Country
      • 11.3.1.3 Asia Pacific Hybrid Market by Country
    • 11.3.2 Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Data Source
      • 11.3.2.1 Asia Pacific Clinical Data Market by Country
      • 11.3.2.2 Asia Pacific Medical Imaging Data Market by Country
      • 11.3.2.3 Asia Pacific Wearables & IoT Data Market by Country
      • 11.3.2.4 Asia Pacific Lab Test Data Market by Country
      • 11.3.2.5 Asia Pacific Genomic Data Market by Country
    • 11.3.3 Asia Pacific Diagnostic Analytics in Healthcare Industry Market by End-User
      • 11.3.3.1 Asia Pacific Hospitals Market by Country
      • 11.3.3.2 Asia Pacific Diagnostic Laboratories Market by Country
      • 11.3.3.3 Asia Pacific Clinics and Physician Practices Market by Country
      • 11.3.3.4 Asia Pacific Research & Academic Institutes Market by Country
      • 11.3.3.5 Asia Pacific Insurance Companies & Other Market by Country
    • 11.3.4 Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Type
      • 11.3.4.1 Asia Pacific Predictive Analytics Market by Country
      • 11.3.4.2 Asia Pacific Prescriptive Analytics Market by Country
      • 11.3.4.3 Asia Pacific Descriptive Analytics Market by Country
      • 11.3.4.4 Asia Pacific Diagnostic Analytics Market by Country
    • 11.3.5 Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Technology
      • 11.3.5.1 Asia Pacific Artificial Intelligence (AI) & Machine Learning (ML) Market by Country
      • 11.3.5.2 Asia Pacific Big Data Analytics Market by Country
      • 11.3.5.3 Asia Pacific Cloud-Based Analytics Market by Country
      • 11.3.5.4 Asia Pacific Natural Language Processing (NLP)s Market by Country
      • 11.3.5.5 Asia Pacific Other Technology Market by Country
    • 11.3.6 Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.3.6.1 Asia Pacific Disease Detection & Diagnosis Market by Country
      • 11.3.6.2 Asia Pacific Clinical Decision Support Market by Country
      • 11.3.6.3 Asia Pacific Personalized Treatment Market by Country
      • 11.3.6.4 Asia Pacific Radiology & Medical Imaging Market by Country
      • 11.3.6.5 Asia Pacific Patient Monitoring and Remote Diagnostics Market by Country
      • 11.3.6.6 Asia Pacific Other Application Market by Country
    • 11.3.7 Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Country
      • 11.3.7.1 China Diagnostic Analytics in Healthcare Industry Market
        • 11.3.7.1.1 China Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.3.7.1.2 China Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.3.7.1.3 China Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.3.7.1.4 China Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.3.7.1.5 China Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.3.7.1.6 China Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.3.7.2 Japan Diagnostic Analytics in Healthcare Industry Market
        • 11.3.7.2.1 Japan Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.3.7.2.2 Japan Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.3.7.2.3 Japan Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.3.7.2.4 Japan Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.3.7.2.5 Japan Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.3.7.2.6 Japan Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.3.7.3 India Diagnostic Analytics in Healthcare Industry Market
        • 11.3.7.3.1 India Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.3.7.3.2 India Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.3.7.3.3 India Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.3.7.3.4 India Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.3.7.3.5 India Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.3.7.3.6 India Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.3.7.4 South Korea Diagnostic Analytics in Healthcare Industry Market
        • 11.3.7.4.1 South Korea Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.3.7.4.2 South Korea Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.3.7.4.3 South Korea Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.3.7.4.4 South Korea Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.3.7.4.5 South Korea Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.3.7.4.6 South Korea Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.3.7.5 Singapore Diagnostic Analytics in Healthcare Industry Market
        • 11.3.7.5.1 Singapore Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.3.7.5.2 Singapore Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.3.7.5.3 Singapore Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.3.7.5.4 Singapore Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.3.7.5.5 Singapore Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.3.7.5.6 Singapore Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.3.7.6 Malaysia Diagnostic Analytics in Healthcare Industry Market
        • 11.3.7.6.1 Malaysia Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.3.7.6.2 Malaysia Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.3.7.6.3 Malaysia Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.3.7.6.4 Malaysia Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.3.7.6.5 Malaysia Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.3.7.6.6 Malaysia Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.3.7.7 Rest of Asia Pacific Diagnostic Analytics in Healthcare Industry Market
        • 11.3.7.7.1 Rest of Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.3.7.7.2 Rest of Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.3.7.7.3 Rest of Asia Pacific Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.3.7.7.4 Rest of Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.3.7.7.5 Rest of Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.3.7.7.6 Rest of Asia Pacific Diagnostic Analytics in Healthcare Industry Market by Application
  • 11.4 LAMEA Diagnostic Analytics in Healthcare Industry Market
    • 11.4.1 LAMEA Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
      • 11.4.1.1 LAMEA Cloud-Based Market by Country
      • 11.4.1.2 LAMEA On-Premise Market by Country
      • 11.4.1.3 LAMEA Hybrid Market by Country
    • 11.4.2 LAMEA Diagnostic Analytics in Healthcare Industry Market by Data Source
      • 11.4.2.1 LAMEA Clinical Data Market by Country
      • 11.4.2.2 LAMEA Medical Imaging Data Market by Country
      • 11.4.2.3 LAMEA Wearables & IoT Data Market by Country
      • 11.4.2.4 LAMEA Lab Test Data Market by Country
      • 11.4.2.5 LAMEA Genomic Data Market by Country
    • 11.4.3 LAMEA Diagnostic Analytics in Healthcare Industry Market by End-User
      • 11.4.3.1 LAMEA Hospitals Market by Country
      • 11.4.3.2 LAMEA Diagnostic Laboratories Market by Country
      • 11.4.3.3 LAMEA Clinics and Physician Practices Market by Country
      • 11.4.3.4 LAMEA Research & Academic Institutes Market by Country
      • 11.4.3.5 LAMEA Insurance Companies & Other Market by Country
    • 11.4.4 LAMEA Diagnostic Analytics in Healthcare Industry Market by Type
      • 11.4.4.1 LAMEA Predictive Analytics Market by Country
      • 11.4.4.2 LAMEA Prescriptive Analytics Market by Country
      • 11.4.4.3 LAMEA Descriptive Analytics Market by Country
      • 11.4.4.4 LAMEA Diagnostic Analytics Market by Country
    • 11.4.5 LAMEA Diagnostic Analytics in Healthcare Industry Market by Technology
      • 11.4.5.1 LAMEA Artificial Intelligence (AI) & Machine Learning (ML) Market by Country
      • 11.4.5.2 LAMEA Big Data Analytics Market by Country
      • 11.4.5.3 LAMEA Cloud-Based Analytics Market by Country
      • 11.4.5.4 LAMEA Natural Language Processing (NLP)s Market by Country
      • 11.4.5.5 LAMEA Other Technology Market by Country
    • 11.4.6 LAMEA Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.4.6.1 LAMEA Disease Detection & Diagnosis Market by Country
      • 11.4.6.2 LAMEA Clinical Decision Support Market by Country
      • 11.4.6.3 LAMEA Personalized Treatment Market by Country
      • 11.4.6.4 LAMEA Radiology & Medical Imaging Market by Country
      • 11.4.6.5 LAMEA Patient Monitoring and Remote Diagnostics Market by Country
      • 11.4.6.6 LAMEA Other Application Market by Country
    • 11.4.7 LAMEA Diagnostic Analytics in Healthcare Industry Market by Country
      • 11.4.7.1 Brazil Diagnostic Analytics in Healthcare Industry Market
        • 11.4.7.1.1 Brazil Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.4.7.1.2 Brazil Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.4.7.1.3 Brazil Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.4.7.1.4 Brazil Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.4.7.1.5 Brazil Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.4.7.1.6 Brazil Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.4.7.2 Argentina Diagnostic Analytics in Healthcare Industry Market
        • 11.4.7.2.1 Argentina Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.4.7.2.2 Argentina Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.4.7.2.3 Argentina Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.4.7.2.4 Argentina Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.4.7.2.5 Argentina Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.4.7.2.6 Argentina Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.4.7.3 UAE Diagnostic Analytics in Healthcare Industry Market
        • 11.4.7.3.1 UAE Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.4.7.3.2 UAE Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.4.7.3.3 UAE Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.4.7.3.4 UAE Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.4.7.3.5 UAE Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.4.7.3.6 UAE Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.4.7.4 Saudi Arabia Diagnostic Analytics in Healthcare Industry Market
        • 11.4.7.4.1 Saudi Arabia Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.4.7.4.2 Saudi Arabia Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.4.7.4.3 Saudi Arabia Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.4.7.4.4 Saudi Arabia Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.4.7.4.5 Saudi Arabia Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.4.7.4.6 Saudi Arabia Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.4.7.5 South Africa Diagnostic Analytics in Healthcare Industry Market
        • 11.4.7.5.1 South Africa Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.4.7.5.2 South Africa Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.4.7.5.3 South Africa Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.4.7.5.4 South Africa Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.4.7.5.5 South Africa Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.4.7.5.6 South Africa Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.4.7.6 Nigeria Diagnostic Analytics in Healthcare Industry Market
        • 11.4.7.6.1 Nigeria Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.4.7.6.2 Nigeria Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.4.7.6.3 Nigeria Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.4.7.6.4 Nigeria Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.4.7.6.5 Nigeria Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.4.7.6.6 Nigeria Diagnostic Analytics in Healthcare Industry Market by Application
      • 11.4.7.7 Rest of LAMEA Diagnostic Analytics in Healthcare Industry Market
        • 11.4.7.7.1 Rest of LAMEA Diagnostic Analytics in Healthcare Industry Market by Deployment Mode
        • 11.4.7.7.2 Rest of LAMEA Diagnostic Analytics in Healthcare Industry Market by Data Source
        • 11.4.7.7.3 Rest of LAMEA Diagnostic Analytics in Healthcare Industry Market by End-User
        • 11.4.7.7.4 Rest of LAMEA Diagnostic Analytics in Healthcare Industry Market by Type
        • 11.4.7.7.5 Rest of LAMEA Diagnostic Analytics in Healthcare Industry Market by Technology
        • 11.4.7.7.6 Rest of LAMEA Diagnostic Analytics in Healthcare Industry Market by Application

Chapter 12. Company Profiles

  • 12.1 Siemens Healthineers AG (Siemens AG)
    • 12.1.1 Company Overview
    • 12.1.2 Financial Analysis
    • 12.1.3 Segmental and Regional Analysis
    • 12.1.4 Research & Development Expense
    • 12.1.5 Recent strategies and developments:
      • 12.1.5.1 Partnerships, Collaborations, and Agreements:
      • 12.1.5.2 Acquisition and Mergers:
    • 12.1.6 SWOT Analysis
  • 12.2 Abbott Laboratories
    • 12.2.1 Company Overview
    • 12.2.2 Financial Analysis
    • 12.2.3 Segmental and Regional Analysis
    • 12.2.4 Research & Development Expense
    • 12.2.5 Recent strategies and developments:
      • 12.2.5.1 Product Launches and Product Expansions:
      • 12.2.5.2 Acquisition and Mergers:
    • 12.2.6 SWOT Analysis
  • 12.3 F. Hoffmann-La Roche Ltd.
    • 12.3.1 Company Overview
    • 12.3.2 Financial Analysis
    • 12.3.3 Segmental and Regional Analysis
    • 12.3.4 Research & Development Expense
    • 12.3.5 Recent strategies and developments:
      • 12.3.5.1 Partnerships, Collaborations, and Agreements:
      • 12.3.5.2 Product Launches and Product Expansions:
      • 12.3.5.3 Acquisition and Mergers:
    • 12.3.6 SWOT Analysis
  • 12.4 Danaher Corporation
    • 12.4.1 Company Overview
    • 12.4.2 Financial Analysis
    • 12.4.3 Segmental and Regional Analysis
    • 12.4.4 Research & Development Expense
    • 12.4.5 Recent strategies and developments:
      • 12.4.5.1 Partnerships, Collaborations, and Agreements:
      • 12.4.5.2 Acquisition and Mergers:
    • 12.4.6 SWOT Analysis
  • 12.5 Qiagen N.V.
    • 12.5.1 Company Overview
    • 12.5.2 Financial Analysis
    • 12.5.3 Regional Analysis
    • 12.5.4 Research & Development Expenses
    • 12.5.5 Recent strategies and developments:
      • 12.5.5.1 Partnerships, Collaborations, and Agreements:
      • 12.5.5.2 Acquisition and Mergers:
    • 12.5.6 SWOT Analysis
  • 12.6 Medtronic PLC
    • 12.6.1 Company overview
    • 12.6.2 Financial Analysis
    • 12.6.3 Segmental and Regional Analysis
    • 12.6.4 Research & Development Expenses
    • 12.6.5 Recent strategies and developments:
      • 12.6.5.1 Partnerships, Collaborations, and Agreements:
    • 12.6.6 SWOT Analysis
  • 12.7 Illumina, Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Financial Analysis
    • 12.7.3 Segment and Regional Analysis
    • 12.7.4 Research & Development Expense
    • 12.7.5 Recent strategies and developments:
      • 12.7.5.1 Product Launches and Product Expansions:
      • 12.7.5.2 Acquisition and Mergers:
    • 12.7.6 SWOT Analysis
  • 12.8 Thermo Fisher Scientific, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Financial Analysis
    • 12.8.3 Segmental and Regional Analysis
    • 12.8.4 Research & Development Expenses
    • 12.8.5 Recent strategies and developments:
      • 12.8.5.1 Partnerships, Collaborations, and Agreements:
      • 12.8.5.2 Acquisition and Mergers:
    • 12.8.6 SWOT Analysis
  • 12.9 Quest Diagnostics Incorporated
    • 12.9.1 Company Overview
    • 12.9.2 Financial Analysis
    • 12.9.3 Segmental Analysis
    • 12.9.4 Recent strategies and developments:
      • 12.9.4.1 Partnerships, Collaborations, and Agreements:
    • 12.9.5 SWOT Analysis
  • 12.10. GE HealthCare Technologies, Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Financial Analysis
    • 12.10.3 Segmental and Regional Analysis
    • 12.10.4 Research & Development Expenses
    • 12.10.5 Recent strategies and developments:
      • 12.10.5.1 Partnerships, Collaborations, and Agreements:
      • 12.10.5.2 Product Launches and Product Expansions:
    • 12.10.6 SWOT Analysis

Chapter 13. Winning Imperatives of Diagnostic Analytics in Healthcare Industry Market

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제